Authors:
CHAO Y
CHAN WK
BIRKHOFER MJ
HU OYP
WANG SS
HUANG YS
LIU M
WHANGPENG J
CHI KH
LUI WY
LEE SD
Citation: Y. Chao et al., PHASE-II AND PHARMACOKINETIC STUDY OF PACLITAXEL THERAPY FOR UNRESECTABLE HEPATOCELLULAR-CARCINOMA PATIENTS, British Journal of Cancer, 78(1), 1998, pp. 34-39
Authors:
HUIZING MT
VANWARMERDAM LJC
ROSING H
SCHAEFERS MCW
LAI A
HELMERHORST TJM
VEENHOF CHN
BIRKHOFER MJ
RODENHUIS S
BEIJNEN JH
TENBOKKELHUININK WW
Citation: Mt. Huizing et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE COMBINATION PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY IN STAGE-III AND STAGE-IV OVARIAN-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1953-1964
Authors:
SONNICHSEN DS
SUMMERILL RS
RAYMOND RH
WEINER RS
ABRAMS JR
BIRKHOFER MJ
Citation: Ds. Sonnichsen et al., PHARMACOKINETIC (PK) MODELING OF BMS-188667 (CTLA4IG), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 104-104